Table 2.

Medians survival times for groups of different variables among adult on first line ART in public health facilities of Arba-Minch Town, Gamo Gofa Zone, Southern, Ethiopia, 2018

Variables	Median survival time	Std. Error of the Median	95% CI of the Median
			Lower bound Upper bound
Type of health facilities
Hospital	19	1.39	16	24
Health center	23	1.12	12	39
Sex
Male	21	1.89	18	30
Female	18	1.98	12	26
Residence
Urban	20	1.89	16	24
Rural	21	1.65	15	37
Disclosure status
Disclosed	24	1.40	18	30
Not disclosed	18	1.32	15	24
Substance use
Yes	18	1.53	12	27
No	23	1.85	18	31
Time since HIV diagnosis
≤3 Years	18	1.03	14	23
>3Years	24	3.29	19	42
Duration on ART (months)
<12	9	0.28	7	11
≥12	24	2.41	20	31
Baseline WHO clinical stage
Mild WHO stage	24	3.50	16	33
Advance stage	20	1.40	15	24
Past OI before HARRT initiation
Yes	17	0.56	12	23
No	24	0.58	20	33
Baseline weight
≥ 50 Kg	23	2.54	8	35
< 50 Kg	20	2.24	18	24
Baseline BMI
<18.5	19	2.34	12	24
≥18.5	24	1.75	18	35
Functional status
Working	23	1.94	12	30
Ambulatory	36	3.84	18	44
Bedridden	18	1.49	12	24
Baseline CD4 Count
≥200cells/mm3	24	1.05	19	36
<200 cells/mm3	18	1.55	14	23
Cotrimoxazole preventive therapy
Yes	24	2.99	18	36
No	18	0.49	14	21
Isoniazid preventive therapy
Yes	19	2.52	15	27
No	21	1.62	17	30
Adherence level
Good	24	2.01	19	43
Fair	20	1.68	14	27
Poor	18	0.39	12	21
Initial regimen substitution
Yes	23	2.16	17	30
No	20	1.7	14	24
First line regimen started
Nevirapine based	24	3.03	17	39
Efavirenz based	20	1.29	15	24